Ionis Pharmaceuticals Inc (IONS)
41.82
-0.64
(-1.50%)
USD |
NASDAQ |
Apr 25, 16:00
41.82
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Free Cash Flow: -335.52M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -335.52M |
| September 30, 2023 | -573.62M |
| June 30, 2023 | -492.84M |
| March 31, 2023 | -405.00M |
| December 31, 2022 | -294.47M |
| September 30, 2022 | 110.43M |
| June 30, 2022 | 81.74M |
| March 31, 2022 | 35.38M |
| December 31, 2021 | 12.90M |
| September 30, 2021 | -95.70M |
| June 30, 2021 | -58.77M |
| March 31, 2021 | -45.24M |
| December 31, 2020 | -5.156M |
| September 30, 2020 | 172.64M |
| June 30, 2020 | 165.29M |
| March 31, 2020 | 188.32M |
| December 31, 2019 | 309.34M |
| September 30, 2019 | 153.84M |
| June 30, 2019 | 153.72M |
| March 31, 2019 | 678.61M |
| December 31, 2018 | 585.25M |
| September 30, 2018 | 485.20M |
| June 30, 2018 | 524.88M |
| March 31, 2018 | 27.93M |
| December 31, 2017 | 136.29M |
| Date | Value |
|---|---|
| September 30, 2017 | 92.28M |
| June 30, 2017 | 105.36M |
| March 31, 2017 | 71.59M |
| December 31, 2016 | -123.63M |
| September 30, 2016 | -133.56M |
| June 30, 2016 | -122.32M |
| March 31, 2016 | -22.98M |
| December 31, 2015 | 9.377M |
| September 30, 2015 | 115.98M |
| June 30, 2015 | 83.11M |
| March 31, 2015 | -15.18M |
| December 31, 2014 | -4.819M |
| September 30, 2014 | -86.83M |
| June 30, 2014 | -23.50M |
| March 31, 2014 | 35.57M |
| December 31, 2013 | 58.13M |
| September 30, 2013 | 108.83M |
| June 30, 2013 | 18.85M |
| March 31, 2013 | -7.621M |
| December 31, 2012 | -3.294M |
| September 30, 2012 | -63.10M |
| June 30, 2012 | -63.79M |
| March 31, 2012 | -90.04M |
| December 31, 2011 | -125.80M |
| September 30, 2011 | -127.56M |
Free Cash Flow Range, Past 5 Years
-573.62M
Minimum
Sep 2023
309.34M
Maximum
Dec 2019
-48.56M
Average
12.90M
Median
Dec 2021
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -325.71M |
| Viking Therapeutics Inc | -73.38M |
| Alnylam Pharmaceuticals Inc | 41.94M |
| Akero Therapeutics Inc | -145.37M |
| 89bio Inc | -129.19M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 32.86M |
| Cash from Investing (Quarterly) | -26.71M |
| Cash from Financing (Quarterly) | 40.72M |
| Free Cash Flow Per Share (Quarterly) | 0.229 |
| Free Cash Flow to Equity (Quarterly) | 29.52M |
| Free Cash Flow to Firm (Quarterly) | 108.04M |
| Free Cash Flow Yield | -5.60% |